Foundation for Venous & Lymphatic Diseases (EIN 203421567) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2005

Legal Domicile

Principal Officer

John Mangold

Phone

5103466800

Tax Period

2024-07-01 to 2025-06-30

Foundation for Venous & Lymphatic Diseases, founded in 2005, is a small nonprofit in the Philanthropy & Grantmaking sector that reported $161K in total revenue in fiscal year 2024. Revenue fell 73% from the prior year — a significant decline worth monitoring. Expenses of $269K exceeded revenue, resulting in a 67% operating deficit.

Mission

To advance, support and encourage the medical practice of phlebology by providing financial and technical resources.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $160,879

Program Service Revenue $0

Investment Income $1

Other Revenue $0

TOTAL REVENUE $160,880

Expense Breakdown

Grants Paid $62,815

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $62,815

Other Expenses $206,063

TOTAL EXPENSES $268,878

Year-over-Year Comparison

	2024	2023	Change
Revenue	$160,880	$590,049	-0.7%
Expenses	$268,878	$529,153	-0.5%
Net Income	$-107,998	$60,896	-2.8%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Nick Morrison	Secretary	1.00	Officer Director	$0	$0	$0
Philip Sporidis	Director	1.00	Director	$0	$0	$0
John Mangold	Acting Executive Director	1.00	Director	$0	$0	$0
James Albert	Director	1.00	Director	$0	$0	$0
Sharon Brownlee	Director	1.00	Director	$0	$0	$0
Kristie Burns	Director	1.00	Director	$0	$0	$0
Liza E Giammaria	Director	1.00	Director	$0	$0	$0
Lornell Hansen	Director	1.00	Director	$0	$0	$0
Sanjiv Lakhanpal	Director	1.00	Director	$0	$0	$0
Mark Meissner	Past Chair	1.00	Director	$0	$0	$0
Erin Murphy	Director	1.00	Director	$0	$0	$0
Diana Neuhardt	Director	1.00	Director	$0	$0	$0
AJ Riviezzo	Treasurer	1.00	Officer Director	$0	$0	$0
Robert Worthington-Kirsch	Director	1.00	Director	$0	$0	$0
Eric Ansart	Diredtor	1.00	Director	$0	$0	$0
Jeff Lemaster	Director	1.00	Director	$0	$0	$0
Matthew M Melin	Director	1.00	Director	$0	$0	$0
Lynn Oster	Director	1.00	Director	$0	$0	$0
Marlin Schul	Director	1.00	Director	$0	$0	$0
Kathleen D Gibson	Chairman of the Board	1.00	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$160,880	$268,878	$114,643	$-107,998
2024	$737,143	$676,246	$114,543	$60,897
2023	$544,982	$634,689	$143,354	$-89,707

Foundation for Venous & Lymphatic Diseases